IndraLab
Statements
UCHL5 activates Neoplasm Invasiveness. 4 / 4
|
4
reach
"In contrast to BAP1, which inhibits RCC by upregulation of STING activity and activation of interferon, UCHL5 promotes RCC by regulating immune infiltration and antigen presentation of B cells, and its increased level in RCC blood samples suggest its potential as a prognostic marker."